Cardiovascular Disease (CVD)

Higher CV Event Rate Linked to Low Hb in HD Patients

Jody A. Charnow May 11, 2012

NATIONAL HARBOR, Md.—Hemodialysis (HD) patients receiving either epoetin or peginesatide who achieve low hemoglobin (Hb) levels have an increased rate of cardiovascular (CV) events, according to new data presented at the National Kidney Foundation 2012 Spring Clinical Meetings.

Post-Angiography AKI May Deter Heart Drug Use

Rosemary Frei, MSc April 28, 2012

ST. JOHN'S, NEWFOUNDLAND—Older patients who have coronary angiography and then experience acute kidney injury (AKI) are significantly less likely to receive cardiovascular medications than their counterparts who do not develop AKI, a new study shows.

Dialysis May Help Some Patients with Treatment-Resistant CHF

Jody A. Charnow April 11, 2012

Dialysis may improve outcomes in patients suffering from treatment-resistant congestive heart failure (CHF) accompanied by severe renal insufficiency, new findings suggest.

Heart Failure Linked to Orthostatic Hypotension

Jody A. Charnow April 10, 2012

Orthostatic hypotension predicts incident heart failure among middle-aged adults, especially those aged 45-55 years old, researchers reported online ahead of print in Hypertension.

Endothelial Dysfunction in CKD Patients Linked to Calcitonin

Jody A. Charnow April 05, 2012

Serum calcitonin is independently related with endothelial dysfunction in patients with chronic kidney disease (CKD), data suggest.

Kidney Donation Does Not Increase CV Risk

Jody A. Charnow April 01, 2012

Kidney donors are at no greater risk for cardiovascular (CV) events or death than non-donors.

Arteriovenous Fistulas May Increase Heart Failure Risk

Jody A. Charnow March 21, 2012

Pre-emptive placement of an arteriovenous fistula (AVF) in pre-dialysis patients with advanced chronic kidney disease (CKD) may increase their risk of congestive heart failure (CHF), a study found.

Nut Consumers Have Lower Health Risks

Jody A. Charnow March 07, 2012

Nut consumption is associated with a decreased prevalence of certain risk factors for cardiovascular disease, type 2 diabetes, and metabolic syndrome, according to a recent study.

Renal Dysfunction After Radical Nephrectomy Raises Cardiovascular Risks

Jody A. Charnow February 25, 2012

PARIS—Renal dysfunction following radical nephrectomy (RN) for renal cancer is associated with an increased risk of cardiovascular (CV) events and non-cancer-related mortality, Japanese researchers reported at the 27th Annual Congress of the European Association of Urology.

Change in Fitness or Fatness Impacts Cardio Risk Factors

February 06, 2012

Positive change in fitness or fatness impacts cholesterol, hypertension, metabolic syndrome

Severe Vitamin D Deficiency Raises Death Risk in Hemodialysis Patients

Jody A. Charnow February 02, 2012

Hemodialysis (HD) patients with severe vitamin D deficiency are more than twice as likely to die from any cause compared with those who have sufficient levels of the vitamin, according to a German study.

Newer Antihypertensive Agents May Be No Better than Diuretics

Rosemary Frei, MSc January 20, 2012

Calcium channel blockers (CCBs) and ACE inhibitors may be no better than diuretics at preventing cardiovascular deaths in patients with hypertension, according to a follow-up study of patients in a seminal antihypertensive trial. In addition, CCBs and ACE inhibitors may increase cardiovascular risks.

Myocardial Infarctions Frequently Unrecognized in Kidney Disease Patients

Jody A. Charnow January 04, 2012

Myocardial infarction (MI) often goes unrecognized in patients with chronic kidney disease (CKD), and it is associated with a significantly increased risk of death, according to researchers.

EPO Resistance May Predict Cardiovascular Events

Jody A. Charnow December 05, 2011

Early identification of erythropoietin (EPO) resistance may help clinicians predict cardiovascular risk in hemodialysis (HD) patients, according to researchers.

No Benefit To Adding Niacin to Statin Rx

Jody A. Charnow December 01, 2011

Adding niacin to statin therapy offers no incremental clinical benefit to patients with atherosclerotic cardiovascular disease and LDL cholesterol levels below 70 mg/dL, according to study findings published in the New England Journal of Medicine (online ahead of print).

Telephone Intervention Can Help Obese Patients Lose Weight

Jill Stein November 16, 2011

ORLANDO—A weight loss program delivered by telephone can be just as effective in obese patients with at least one cardiovascular risk factor as a weight loss program delivered with in-person support, researchers reported at the American Heart Association Scientific Sessions 2011.

Kidney Transplants Fail to Stop Coronary Artery Calcification

Stephan Cho November 02, 2011

Renal transplantation does not stop or reverse coronary artery calcification (CAC), according to researchers.

CVD Varies by Race in CKD Population

Jody A. Charnow November 01, 2011

Researchers who studied a cohort of individuals with mild-to-moderate chronic kidney disease have identified racial differences in the prevalence of self-reported cardiovascular disease (CVD) and indicators of subclinical CVD.

Drug-Eluting Stents Safe for Most Older CKD Patients

Stephan Cho October 20, 2011

Drug-eluting stents are safe to use in older patients undergoing percutaneous coronary interventions regardless of renal function, researchers concluded.

Two RRT Modalities Offer Similar Survival

Daniel M. Keller, PhD October 01, 2011

PRAGUE—Two forms of renal replacement therapy (RRT) for end-stage renal disease are associated with similar rates of mortality overall and from cardiovascular (CV) causes, according to a new study.

Our exclusive coverage of Kidney Week 2011 in Philadelphia includes interviews, videos and noteworthy clinical reports.

Sections: Anemia | Transplantation
Secondary Hyperparathyroidism | General News
More: Videos

Your Practice

The move from ICD-9-CM to ICD-10 is enough to strike fear into the hearts of physicians and staff alike. Making the leap from 14,000 codes to almost 69,000, topped with the huge cost to make that change, is understandably daunting.

Read more on
Coping with ICD-10

Have any practice management topics that you'd like us to cover?
Let us know.

On The Forefront

Sickle Cell Trait and Medullary Renal Carcinoma

A 55-year-old Caucasian woman initially presented to one of Cleveland Clinic's regional outpatient urology clinics with gross hematuria and an obstructing right ureteral stone.

Clinical Quiz

Small Renal Masses and Drug-Eluting Stents — How to Best Balance the Risks?

A 55-year-old male with significant history of coronary artery disease is found to have an intraparenchymal 2 cm left-enhancing small renal mass. Answer the quiz correctly and you'll have a chance to win an American Express gift card.

Expert Q&A

Optimal Sequencing of the New Prostate Cancer Drugs: An Interview with E. David Crawford, MD

Several new drugs have become available for treating advanced prostate cancer in the past year and a half. Dr. Crawford talks to Renal & Urology News about the possible ways in which these drugs might be used.